China-based phrama R&D company WuXi Pharmatech announced its gross profit on non-GAAP basis increased 42 percent year on year to $ 17.3 million in the fourth quarter of last year

Fourth-Quarter 2010 Highlights

Net revenues grew 20 percent year over year to $88.6 million

Laboratory Services net revenues increased 16 percent year over year to $78.5 million

China-based Laboratory Services net revenues grew 16 percent year over year to $59.6 million

U.S.-based Laboratory Services net revenues increased 17 percent year over year to $18.9 million

Manufacturing Services net revenues increased 59 percent year over year to $10.1 million

GAAP diluted earnings per ADS grew 42 percent year over year to 23 cents

Non-GAAP diluted earnings per ADS grew 29 percent year over year to 28 cents

Full-Year 2010 Highlights

Net revenues grew 24 percent year over year to $334.1 million

Laboratory Services net revenues increased 18 percent year over year to $294.9 million

China-based Laboratory Services net revenues grew 18 percent year over year to $219.4 million

U.S.-based Laboratory Services net revenues increased 18 percent year over year to $75.5 million

Manufacturing Services net revenues increased 95 percent year over year to $39.2 million

GAAP diluted earnings per ADS grew 69 percent year over year to $1.22

Non-GAAP diluted earnings per ADS grew 22 percent year over year to $1.09